Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of ProvayBlue (methylene blue) in acquired methemoglobinemia
2017-000290-37Phase 4Active
- Sponsor
- Provepharma
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylene blue in acquired methemoglobinemia, sponsored by Provepharma. Primary endpoint: Methemoglobin reduction. Started Aug 2017; status: active.
02
Drugs
methylene blue
03
Conditions
acquired methemoglobinemia
Beyond the preview
Go deeper on 2017-000290-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000290-37.